Eric Rowinsky

(Dr. Eric Rowinsky M.D.)

Currently holds positions in Fortress Biotech Inc, Biophytis SA, ImClone LLC, Biogen Inc, Verastem Inc and Fortress Biotech Inc

Positions

Position Company Period
Co-Vice Chairman and Director Fortress Biotech Inc Dec. 31, 2015 -
Director Biophytis SA None -
Executive Vice President - Clinical Research, Chief Medical Officer ImClone LLC Dec. 1, 2007 -
Independent Director Biogen Inc March 22, 2010 -
Independent Director Verastem Inc May 3, 2017 -
Vice Chairman of the Board Fortress Biotech Inc Jan. 27, 2014 -
Chairman of the Board Navidea Biopharmaceuticals Inc Sept. 22, 2016 - March 31, 2018
Director Navidea Biopharmaceuticals Inc July 1, 2010 - Sept. 22, 2016
Vice Chairman of the Board Fortress Biotech Inc Jan. 27, 2014 - Dec. 31, 2015
Executive Vice President, Chief Medical Officer and Head of Research and Development Stemline Therapeutics Inc Nov. 1, 2011 - Oct. 27, 2015
Co-Vice Chairman of the Board Fortress Biotech Inc Oct. 1, 2010 - Jan. 27, 2014
Eric Rowinsky's trades of Biogen Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-20 2024-02-15
US Biogen Inc (BIIB)
B Purchase
455 +2.3%
222.54
USD 101,256 		455 +2.3% 222.54 USD 101,256
2023-02-14 2023-02-10
B Purchase
11,976 +1.3%
0.84
USD 10,000 		11,976 +1.3% 0.84 USD 10,000
2021-04-09 2021-03-02
S Sale
10,000 -1.4%
4.45
USD 44,500 		10,000 -1.4% 4.45 USD 44,500
2021-04-09 2021-02-19
S Sale
8,000 -1.1%
4.31
USD 34,480 		8,000 -1.1% 4.31 USD 34,480
2021-04-09 2021-02-18
S Sale
6,000 -0.8%
4.20
USD 25,200 		6,000 -0.8% 4.20 USD 25,200
2021-04-09 2021-02-16
S Sale
2,000 -0.3%
3.86
USD 7,720 		2,000 -0.3% 3.86 USD 7,720
2021-04-09 2021-02-05
S Sale
4,000 -0.5%
3.80
USD 15,200 		4,000 -0.5% 3.80 USD 15,200
2024-01-24 2017-09-05
US Verastem Inc (VSTM)
B Purchase
2,000 +inf%
3.84
USD 7,680 		2,000 +inf% 3.84 USD 7,680
// ... existing code ... // ... rest of the file ...